News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,183 Results
Type
Article (54381)
Company Profile (333)
Press Release (699469)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (215452)
Career Advice (2263)
Deals (37639)
Drug Delivery (110)
Drug Development (84696)
Employer Resources (176)
FDA (17287)
Job Trends (15994)
News (365425)
Policy (35529)
Tag
Academia (2873)
Accelerated approval (5)
Adcomms (25)
Allergies (89)
Alliances (52914)
ALS (99)
Alzheimer's disease (1458)
Antibody-drug conjugate (ADC) (139)
Approvals (17274)
Artificial intelligence (311)
Autoimmune disease (28)
Automation (16)
Bankruptcy (379)
Best Places to Work (12251)
BIOSECURE Act (19)
Biosimilars (110)
Biotechnology (231)
Bladder cancer (82)
Brain cancer (31)
Breast cancer (297)
Cancer (2381)
Cardiovascular disease (190)
Career advice (1897)
Career pathing (33)
CAR-T (164)
Cell therapy (457)
Cervical cancer (21)
Clinical research (68655)
Collaboration (891)
Company closure (1)
Compensation (551)
Complete response letters (24)
COVID-19 (2774)
CRISPR (46)
C-suite (259)
Cystic fibrosis (104)
Data (2270)
Decentralized trials (2)
Denatured (29)
Depression (51)
Diabetes (284)
Diagnostics (6685)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (140)
Drug pricing (115)
Drug shortages (30)
Duchenne muscular dystrophy (96)
Earnings (89488)
Editorial (41)
Employer branding (21)
Employer resources (151)
Events (119258)
Executive appointments (758)
FDA (18627)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (799)
Gene editing (117)
Generative AI (30)
Gene therapy (334)
GLP-1 (785)
Government (4800)
Grass and pollen (4)
Guidances (81)
Healthcare (20244)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (132)
Indications (30)
Infectious disease (2923)
Inflammatory bowel disease (149)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (97)
Interviews (353)
IPO (17027)
IRA (44)
Job creations (4168)
Job search strategy (1609)
Kidney cancer (11)
Labor market (38)
Layoffs (507)
Leadership (21)
Legal (8713)
Liver cancer (79)
Lung cancer (336)
Lymphoma (158)
Machine learning (7)
Management (61)
Manufacturing (336)
MASH (71)
Medical device (14496)
Medtech (14501)
Mergers & acquisitions (21176)
Metabolic disorders (740)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (105)
Neuropsychiatric disorders (32)
Neuroscience (2042)
NextGen: Class of 2025 (7105)
Non-profit (4821)
Now hiring (39)
Obesity (395)
Opinion (239)
Ovarian cancer (78)
Pain (96)
Pancreatic cancer (88)
Parkinson's disease (156)
Partnered (21)
Patents (243)
Patient recruitment (115)
Peanut (49)
People (60960)
Pharmaceutical (78)
Pharmacy benefit managers (20)
Phase I (21400)
Phase II (30135)
Phase III (22523)
Pipeline (1251)
Policy (150)
Postmarket research (2802)
Preclinical (9229)
Press Release (72)
Prostate cancer (110)
Psychedelics (33)
Radiopharmaceuticals (260)
Rare diseases (405)
Real estate (6447)
Recruiting (66)
Regulatory (24248)
Reports (47)
Research institute (2551)
Resumes & cover letters (385)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (79)
Series A (138)
Series B (92)
Service/supplier (15)
Sickle cell disease (54)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3935)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (43)
The Weekly (35)
Vaccines (759)
Venture capitalists (43)
Weight loss (270)
Women's health (38)
Worklife (16)
Date
Today (137)
Last 7 days (842)
Last 30 days (2823)
Last 365 days (34356)
2025 (11658)
2024 (36769)
2023 (41598)
2022 (52894)
2021 (57640)
2020 (56520)
2019 (49593)
2018 (37583)
2017 (34533)
2016 (34497)
2015 (40509)
2014 (34272)
2013 (29673)
2012 (31914)
2011 (32578)
2010 (31001)
Location
Africa (850)
Alabama (54)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (42413)
Australia (7018)
California (6316)
Canada (2052)
China (552)
Colorado (278)
Connecticut (295)
Delaware (154)
Europe (93222)
Florida (928)
Georgia (220)
Idaho (63)
Illinois (591)
India (27)
Indiana (322)
Iowa (11)
Japan (169)
Kansas (108)
Kentucky (25)
Louisiana (11)
Maine (62)
Maryland (949)
Massachusetts (4793)
Michigan (229)
Minnesota (413)
Mississippi (2)
Missouri (90)
Montana (30)
Nebraska (25)
Nevada (66)
New Hampshire (68)
New Jersey (1790)
New Mexico (30)
New York (1804)
North Carolina (1058)
North Dakota (8)
Northern California (2747)
Ohio (210)
Oklahoma (14)
Oregon (38)
Pennsylvania (1406)
Puerto Rico (12)
Rhode Island (35)
South America (1253)
South Carolina (24)
South Dakota (1)
Southern California (2364)
Tennessee (104)
Texas (941)
United States (24108)
Utah (189)
Virginia (155)
Washington D.C. (67)
Washington State (581)
West Virginia (3)
Wisconsin (57)
754,183 Results for "alveolus inc acquired by merit medical systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Merit Medical Announces Asset Purchase Agreement with EndoGastric Solutions, Inc.®
Merit Medical Systems, Inc., a global leader of healthcare technology, announced it has executed an asset purchase agreement with EndoGastric Solutions, Inc. for a total cash consideration of approximately $105 million.
July 1, 2024
·
18 min read
Press Releases
Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025
April 7, 2025
·
1 min read
Press Releases
Merit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
April 25, 2025
·
27 min read
Press Releases
First Patient Enrolled in Merit Medical’s PREEMIE Study
March 10, 2025
·
3 min read
Business
Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock market on Thursday, August 1, 2024.
June 18, 2024
·
1 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
Press Releases
Alcon Agrees to Acquire LENSAR, Inc.
March 25, 2025
·
9 min read
Press Releases
Inspire Medical Systems, Inc. Announces First Quarter 2025 Financial Results and Updates 2025 Outlook
May 5, 2025
·
13 min read
BioMidwest
Merit Medical Shareholders Elect Silvia M. Perez as New Director
Merit Medical Systems, Inc., a global leader of healthcare technology, announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and Transportation Division at 3M Company, as a director in Merit’s Annual Meeting of Shareholders held on May 15, 2024.
May 16, 2024
·
2 min read
BioMidwest
Merit Medical Launches the Micro ACE™ Advanced Micro-Access System
Merit Medical Systems, Inc., a global leader of healthcare technology, announced commercial release of its US Food and Drug Administration -cleared Micro ACE Advanced Micro-Access System.
March 19, 2024
·
2 min read
1 of 75,419
Next
